Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Renhuan Huang is active.

Publication


Featured researches published by Renhuan Huang.


Journal of Dental Research | 2012

Cognitive Behavioral Therapy for Orthodontic Pain Control A Randomized Trial

J. Wang; Fan Jian; Jing Chen; Niansong Ye; Yuanding Huang; Sheng Wang; Renhuan Huang; J. Pei; P. Liu; L. Zhang; Z.H. Zhao; Q.M. Chen; Wenli Lai; Yunfeng Lin

The objective of this study was to evaluate the efficacy of cognitive behavioral therapy intervention for patients who experienced pain during orthodontic treatment. The baseline characteristics were assessed via questionnaires and oral examinations. Four hundred and fifty eligible individuals were recruited and randomized by computer-generated block randomization into three groups: cognitive behavioral therapy intervention (n = 150), ibuprofen intervention (n = 150), and no intervention (control; n = 150). Primary outcomes were the change from baseline in pain intensity measured with 100-mm Visual Analog Scale (VAS) scores at 1, 2, 3, 7, 14, and 30 days after initial archwire placement. Outcomes assessment was blinded and followed the intention-to-treat principle. One hundred forty-three (95.30%), 145 (96.70%), and 141 (94.00%) individuals in the cognitive behavioral therapy, the ibuprofen, and the control groups, respectively, completed the one-month follow-up evaluations. Those in the cognitive behavioral therapy group showed a greater decrease in mean VAS scores than did those in the control group over the previous five time-points (p < 0.001). Cognitive behavioral therapy was shown to be effective in pain control during the initial stage of orthodontic treatment. The study registration number was ChiCTR-TRC-00000556.


Current Drug Metabolism | 2013

Toxicity of carbon nanotubes.

Jing Wang; Yuanzhi Xu; Zhi Yang; Renhuan Huang; Jing Chen; Raorao Wang; Yunfeng Lin

Carbon nanotubes (CNTs) find their extensive application as a promising material in medicine due to unique characteristics. However, such materials have been accompanied with potentially hazardous effects on human health. The toxicity of CNTs may vary depending on their structural characteristics, surface properties and chemical composition. To gain insight into the toxicity of CNTs in vivo and in vitro, we summarize contributing factors for the toxic effects of CNTs in this review. In addition, we elaborate on the toxic effects and mechanisms in target sites at systemic, organic, cellular, and biomacromolecule levels. Various issues are reported to be effected when exposed to CNTs including (1) blood circulation, (2) lymph circulation, (3) lung, (4) heart, (5) kidney, (6) spleen, (7) bone marrow, and (8) blood brain barrier. Though there have been published reports on the toxic effects of CNTs to date, more studies will still be needed to gain full understanding of their potential toxicity and underlying mechanisms.


Journal of Applied Oral Science | 2013

PAX9 polymorphism and susceptibility to sporadic non-syndromic severe anodontia: a case-control study in southwest China

Jing Wang; Yuanzhi Xu; Jing Chen; Feiyu Wang; Renhuan Huang; Songtao Wu; Linjing Shu; Jingyi Qiu; Zhi Yang; Junjie Xue; Raorao Wang; Jilin Zhao; Wenli Lai

Our research aimed to look into the clinical traits and genetic mutations in sporadic non-syndromic anodontia and to gain insight into the role of mutations of PAX9, MSX1, AXIN2 and EDA in anodontia phenotypes, especially for the PAX9. Material and Methods: The female proband and her family members from the ethnic Han families underwent complete oral examinations and received a retrospective review. Venous blood samples were obtained to screen variants in the PAX9, MSX1, AXIN2, and EDA genes. A case-control study was performed on 50 subjects with sporadic tooth agenesis (cases) and 100 healthy controls, which genotyped a PAX9 gene polymorphism (rs4904210). Results: Intra-oral and panoramic radiographs revealed that the female proband had anodontia denoted by the complete absence of teeth in both the primary and secondary dentitions, while all her family members maintained normal dentitions. Detected in the female proband were variants of the PAX9 and AXIN2 including A240P (rs4904210) of the PAX9, c.148C>T (rs2240308), c.1365A>G (rs9915936) and c.1386C>T (rs1133683) of the AXIN2. The same variants were present in her unaffected younger brother. The PAX9 variations were in a different state in her parents. Mutations in the MSX1 and EDA genes were not identified. No significant diferences were found in the allele and genotype frequencies of the PAX9 polymorphism between the controls and the subjects with sporadic tooth agenesis. Conclusions: These results suggest that the association of A240P with sporadic tooth agenesis still remains obscure, especially for different populations. The genotype/phenotype correlation in congenital anodontia should be verified.


Current Stem Cell Research & Therapy | 2014

Miscellaneous Animal Models Accelerate the Application of Mesenchymal Stem Cells for Cartilage Regeneration

Shuwen Deng; Renhuan Huang; Jing Wang; Shu Zhang; Zhaozhao Chen; Songtao Wu; Yan Jiang; Qiang Peng; Xiaoxiao Cai; Yunfeng Lin

Disorders in articular cartilage affect many people, and are one of the leading causes of infirmity and decreased quality of life in adults. Tissue engineering and regenerative medicine related to cartilage include a broad range of settings and approaches that seek to repair, augment, replace or regenerate cartilage tissue. Formation of new tissue by cartilageforming cells (chondrogenic cells) is a central feature of each of these goals. Mesenchymal stem cell (MSC) transplantation has been introduced to avoid some of the side-effects and complications of current techniques. Different mesenchymal stem cell sources possess different abilitties to regenerate cartilage. However, the use of MSCs for cartilage repair is still at the stage of preclinical and phase I studies, and no comparative clinical studies have been reported. Therefore, it is difficult to make conclusions in human studies. The focus of this review is the role of MSCs, from different sources in which animal models were involved, in tissue-engineering cartilage repair, and research findings aimed at exploring a more rational application of animal models as the basis for future research, with clinical transformation providing a context.


Scientific Reports | 2016

DNA methylation is critical for tooth agenesis: implications for sporadic non-syndromic anodontia and hypodontia

Jing Wang; Ke Sun; Yun Shen; Yuanzhi Xu; Jing Xie; Renhuan Huang; Yiming Zhang; Chenyuan Xu; Xu Zhang; Raorao Wang; Yunfeng Lin

Hypodontia is caused by interactions among genetic, epigenetic, and environmental factors during tooth development, but the actual mechanism is unknown. DNA methylation now appears to play a significant role in abnormal developments, flawed phenotypes, and acquired diseases. Methylated DNA immunoprecipitation (MeDIP) has been developed as a new method of scanning large-scale DNA-methylation profiles within particular regions or in the entire genome. Here, we performed a genome-wide scan of paired DNA samples obtained from 4 patients lacking two mandibular incisors and 4 healthy controls with normal dentition. We scanned another female with non-syndromic anodontia and her younger brother with the same gene mutations of the PAX9,MSX1,AXIN2 and EDA, but without developmental abnormalities in the dentition. Results showed significant differences in the methylation level of the whole genome between the hypodontia and the normal groups. Nine genes were spotted, some of which have not been associated with dental development; these genes were related mainly to the development of cartilage, bone, teeth, and neural transduction, which implied a potential gene cascade network in hypodontia at the methylation level. This pilot study reveals the critical role of DNA methylation in hypodontia and might provide insights into developmental biology and the pathobiology of acquired diseases.


Current Drug Metabolism | 2013

Perspectives on the toxicology of cadmium-based quantum dots.

Feiyu Wang; Linjing Shu; Jing Wang; Xiongfei Pan; Renhuan Huang; Yunfeng Lin; Xiaoxiao Cai

As the number of applications of quantum dots (QDs) grows, the likelihood of exposure increases. Because these metals have the potential for detrimental environmental and health effects, concerns have been raised over our lack of understanding about the fate of these products. Among various types of QDs, cadmium-based quantum dots attract the greatest attention due to their wide applications. To properly assess the potential risk of cadmium-containing QDs, we summarize the current state of academic knowledge on the toxicity of cadmium-based QDs.


Current Stem Cell Research & Therapy | 2014

Emerging roles of microRNAs in neural stem cells.

Sheng Wang; Juan Xu; Rui Ye; Jing Wang; Zhaozhao Chen; Renhuan Huang; Qiang Peng; Yuanzhi Xu; Xiaoxiao Cai

Neural stem cells (NSCs) are a small subset of primitive precursors that generate and maintain the main phenotypes of the nervous system. Their ability to undergo long-term proliferation and neural differentiation endows them with great potential in regenerative medicine. Therefore, the mechanisms by which NSCs are regulated have been widely explored to improve their therapeutic efficacy in treating neurologic disorders. Recent progress has highlighted the significance of microRNAs (miRNAs) in the regulation of NSC behavior. Thus, to sketch out a comprehensive image of the regulatory mechanisms of miRNAs in NSCs, we here summarize existing evidence of the regulatory roles of diversified miRNAs in the proliferation and neural differentiation of NSCs during embryonic neurodevelopment and adult brain maintenance.


Current Stem Cell Research & Therapy | 2016

PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System

Linjing Shu; Renhuan Huang; Songtao Wu; Zhaozhao Chen; Ke Sun; Yan Jiang; Xiaoxiao Cai

Peroxisome proliferator-activated receptor γ (PPARγ) is a versatile member of the ligand-activated nuclear hormone receptor superfamily of transcription factors, with expression in several different cell lines, especially in the digestive system. After being activated by its ligand, PPARγ can suppress the growth of oral, esophageal, gastric, colorectal, liver, biliary, and pancreatic tumor cells, suggesting that PPARγ ligand is a potential anticancer agent in PPARγ-expressing tumors. This review highlights key advances in understanding the effects of PPARγ ligands in the treatment of tumors in the digestive system.


Current Stem Cell Research & Therapy | 2016

The Pleiotropic Effects of PPARs on Vascular Cells and Angiogenesis: Implications for Tissue Engineering

Ke Sun; Renhuan Huang; Songtao Wu; Zhaozhao Chen; Shuwen Deng; Jinglin Zhou; Jing Xie

Angiogenesis is a complex process in which capillaries are produced from blood vessels that already exists. Endothelial cells (ECs) and endothelial progenitor cells (EPCs) are pivotal for this process and for the maintenance/restorage of the endothelium. Decreased numbers and dysfunction of these cells have been related to growing cardiovascular risks. Peroxisome-proliferator-activated receptor (PPAR) is a large family of nuclear receptors, characterized by three isotypes: α, β and γ. Numerous studies have shown that PPAR activation is involved in the pathology of a wide range of cardiovascular diseases and has a role in endothelial function, thrombosis and inflammation, etc., suggesting that PPAR agonists may be good candidates to treat the cardiovascular disease. However, controversial results exist on whether this nuclear receptor is inductive or depressive in the process of angiogenesis. Herein, this review will provide a detailed discussion of the up-to-date investigation of the role of PPARs in angiogenesis, with particular reference to their effects on angiogenesis-related cells--i.e., ECs, EPCs, vascular smooth-muscle cells (VSMCs), macrophages and endometrial cells--and will discuss the current and potential future applications of PPAR activators.


Current Stem Cell Research & Therapy | 2014

Development course and an application strategy for induced pluripotent stem cells in regenerative medicine.

Yuanzhi Xu; Jing Wang; Runyi Mao; Xiaoshan Tang; Renhuan Huang; Raorao Wang; Yunfeng Lin

In 2006, Takahashi and Yamanaka first established induced pluripotent stem cells (iPScs). Since then, numerous improvements have been made in the fields of stem cell research, drug research, modelling of diseases, and the treatment of degenerative diseases. Recently, there has been increasing research involving small molecules for evaluating the efficiency of iPSc generation and reducing the risks of heredity as well as oncogenous problems. However, the molecular mechanisms of iPScs remain to be further explored, to meet the demands of practical applications. With a better understanding of degenerative diseases, more complex treatment strategies for novel regenerative medicine are anticipated, and iPSc technology offers an available pathway. This review focuses on the development and application of iPScs.

Collaboration


Dive into the Renhuan Huang's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge